Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer

The use of immune checkpoint inhibitors (ICIs) has become mainstream in the treatment of non-small cell lung cancer (NSCLC). The idea of harnessing the immune system to fight cancer is fast developing. Neoadjuvant treatment in NSCLC is undergoing unprecedented change. Chemo-immunotherapy combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunzhen, Huang, Sha, Feng, Xiangwei, Xu, Wangjue, Luo, Raojun, Zhu, Ziyi, Zeng, Qingxin, He, Zhengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229830/
https://www.ncbi.nlm.nih.gov/pubmed/37265800
http://dx.doi.org/10.3389/fonc.2023.1145128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229830/
https://www.ncbi.nlm.nih.gov/pubmed/37265800
http://dx.doi.org/10.3389/fonc.2023.1145128

Ejemplares similares